India Gelatine & Chemicals Ltd.
BSE: INDGELA · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock India Gelatine & Chemicals Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
India Gelatine and Chemicals Limited is a manufacturer of pharmaceutical-grade gelatine, ossein, and dicalcium phosphate. The company processes crushed bones to supply high-quality raw materials to the pharmaceutical, food, and photographic industries.
Business Model
The company generates revenue through the integrated manufacturing and sale of gelatine products for human consumption and dicalcium phosphate as a byproduct for the animal feed sector. It leverages both domestic and international markets, including the US, Europe, and Japan, to drive sales.
Growth Outlook
Growth is driven by the sustained demand for pharmaceutical-grade gelatine in capsule manufacturing and the expansion of its byproduct sales in the poultry and animal feed industries. The company continues to focus on maintaining international quality standards to support its export-oriented business model.
Key Risks
- Raw Material Supply. The company is dependent on the consistent availability and quality of crushed bones, which are subject to supply chain fluctuations.
- Regulatory Compliance. Stringent environmental and quality standards in the chemical processing sector pose ongoing operational and compliance risks.
- Currency Volatility. As a significant portion of revenue is derived from exports to the US, Europe, and Japan, the company is exposed to foreign exchange rate fluctuations.
- Commodity Price Risk. Fluctuations in the global market prices for gelatine and dicalcium phosphate can directly impact the company's profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on India Gelatine & Chemicals Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹0 Cr
TTM · standalone
NET PROFIT
₹25 Cr
TTM · standalone
EPS
₹35.39
TTM · standalone
RETURN ON EQUITY
21.8%
TTM · standalone
P/E
10.4x
Q4 FY26 · standalone
EV/EBITDA
7.0x
Q4 FY26 · standalone
EBITDA MARGIN
67.9%
TTM · standalone
NET PROFIT MARGIN
6.8%
Q3 FY25 · standalone
DEBT TO EQUITY
0.0x
Q3 FY25 · standalone
Peers · Specialty Chemicals
| Company | Mkt Cap | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
India Gelatine & Chemicals Ltd.INDGELA | ₹259 Cr | 10.44 | 6.97 | -100.0% | 67.9% | 21.8% | 26.5% | +10.6% |
Black Rose IndusBLACKROSE | ₹586 Cr | 19.65 | 13.25 | -0.2% | 12.5% | 17.8% | 23.9% | +10.3% |
Vipul OrganicsVIPULORG | ₹506 Cr | 55.50 | 28.24 | 16.8% | 10.4% | 9.0% | 13.0% | +26.1% |
Plastiblends India LimitedPLASTIBLEN | ₹487 Cr | 11.78 | 6.76 | 5.5% | 9.2% | 9.7% | 12.8% | +4.3% |
Agastya Energy and Infrastructure LimitedSANGINITA | ₹455 Cr | -19.81 | -83.28 | -23.2% | -3.2% | -18.0% | -14.1% | +581.9% |
Aarti SurfactantAARTISURF | ₹449 Cr | 22.93 | 9.64 | 25.2% | 6.1% | 7.7% | 12.4% | +7.3% |
As of Q4 FY26
Financials
India Gelatine & Chemicals Ltd.
BSE: INDGELA · Specialty Chemicals
Limited coverage
We are not actively covering this company or have limited coverage today. Click to request coverage.
Snapshot
Unlock India Gelatine & Chemicals Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
India Gelatine and Chemicals Limited is a manufacturer of pharmaceutical-grade gelatine, ossein, and dicalcium phosphate. The company processes crushed bones to supply high-quality raw materials to the pharmaceutical, food, and photographic industries.
Business Model
The company generates revenue through the integrated manufacturing and sale of gelatine products for human consumption and dicalcium phosphate as a byproduct for the animal feed sector. It leverages both domestic and international markets, including the US, Europe, and Japan, to drive sales.
Growth Outlook
Growth is driven by the sustained demand for pharmaceutical-grade gelatine in capsule manufacturing and the expansion of its byproduct sales in the poultry and animal feed industries. The company continues to focus on maintaining international quality standards to support its export-oriented business model.
Key Risks
- Raw Material Supply. The company is dependent on the consistent availability and quality of crushed bones, which are subject to supply chain fluctuations.
- Regulatory Compliance. Stringent environmental and quality standards in the chemical processing sector pose ongoing operational and compliance risks.
- Currency Volatility. As a significant portion of revenue is derived from exports to the US, Europe, and Japan, the company is exposed to foreign exchange rate fluctuations.
- Commodity Price Risk. Fluctuations in the global market prices for gelatine and dicalcium phosphate can directly impact the company's profit margins.
Start your research today
Unlock AI insights, financials, peers and live data on India Gelatine & Chemicals Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹0 Cr
TTM · standalone
NET PROFIT
₹25 Cr
TTM · standalone
EPS
₹35.39
TTM · standalone
RETURN ON EQUITY
21.8%
TTM · standalone
P/E
10.4x
Q4 FY26 · standalone
EV/EBITDA
7.0x
Q4 FY26 · standalone
EBITDA MARGIN
67.9%
TTM · standalone
NET PROFIT MARGIN
6.8%
Q3 FY25 · standalone
DEBT TO EQUITY
0.0x
Q3 FY25 · standalone
Peers · Specialty Chemicals
As of Q4 FY26